SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019022
Filing Date
2018-08-03
Accepted
2018-08-03 06:06:15
Documents
94
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-10q_20180630.htm 10-Q 3865475
2 EX-31.1 bmrn-ex311_8.htm EX-31.1 16453
3 EX-31.2 bmrn-ex312_6.htm EX-31.2 16515
4 EX-32.1 bmrn-ex321_7.htm EX-32.1 5892
  Complete submission text file 0001564590-18-019022.txt   15914491

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20180630.xml EX-101.INS 4832430
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20180630.xsd EX-101.SCH 70161
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20180630_cal.xml EX-101.CAL 62991
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20180630_def.xml EX-101.DEF 290364
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20180630_lab.xml EX-101.LAB 483593
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20180630_pre.xml EX-101.PRE 438706
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 18990242
SIC: 2834 Pharmaceutical Preparations